Skip to content
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Cardiology

What Are the Risks of Emboli in Infective Endocarditis?

At a Glance

In infective endocarditis, infected growths on heart valves can break off and block blood flow or spread infection to the brain, lungs, kidneys, spleen, limbs, or other organs. Embolic risk is usually highest early in illness and falls with treatment, but sudden warning signs require emergency care.

If your doctor has mentioned the risk of infection fragments breaking off, they are talking about a complication known as an embolus (plural: emboli). In infective endocarditis, clumps of bacteria or fungi, trapped in a mesh of platelets, clotting proteins (fibrin), and inflammatory cells, grow on the heart valves. These infected masses are called vegetations [1]. Because these masses are fragile (friable), pieces can detach and travel through the bloodstream [1]. When an embolus travels, it can act like a plug, blocking blood flow to critical organs [1].

⚠️ MEDICAL EMERGENCY WARNING
If you experience any of the following, call emergency services (like 911) immediately:

  • Sudden drooping of the face, arm, or leg (especially on one side)
  • Sudden trouble speaking or understanding speech
  • Sudden vision loss or new, severe headache
  • Sudden, severe chest, back, or abdominal pain
  • Extreme shortness of breath
  • An arm or leg that suddenly becomes cold, pale, or painful

Do not wait to see if symptoms improve and do not wait for a scheduled appointment. These can be signs of a time-critical emergency like a stroke or a blocked blood vessel.

How Emboli Travel and What They Do

When a fragment breaks off a vegetation, it moves with your blood until it reaches a blood vessel that is too narrow to pass through. The symptoms this causes depend on the size of the fragment and where it lands, though some small emboli are “silent” and cause no obvious symptoms at all [2].

When an embolus gets stuck, two things can happen:

  1. Infarction: It blocks oxygen-rich blood from reaching the tissues, causing injury or tissue death [1].
  2. Spread of Infection: It may carry live microorganisms into the tissue, potentially creating a new pocket of infection (abscess) or contributing to a weakened, bulging blood vessel (an infectious or mycotic aneurysm) [3][4].

Research shows that embolic events are common in endocarditis, occurring in roughly 30% to 50% of episodes [5][6]. However, this statistic includes both major symptomatic events and “silent” emboli only found on imaging [6][2]. The risk is usually highest early in the disease, often before or right after antibiotics are started, and generally decreases as treatment takes effect [7][8].

Where Do Emboli Travel?

The destination of an embolus depends on which side of the heart is infected:

  • Left-Sided Endocarditis (Mitral or Aortic valves): The left side of the heart pumps blood to the entire body, so emboli here can travel to major organs [6][9].
    • The Brain: The brain is a frequent target [2]. A blocked vessel here causes an ischemic stroke [10]. Emboli can also lead to bleeding in the brain or infectious aneurysms [4].
    • The Spleen and Kidneys: Emboli blocking blood flow to the spleen or kidneys can cause severe back, flank, or abdominal pain, as well as acute kidney injury or blood in the urine, though they can sometimes be painless [11][12].
    • The Limbs and Heart: Less commonly, an embolus can block blood flow to an arm or leg (acute limb ischemia), causing it to become cold and painful, or block a coronary artery causing a heart attack [13][14].
  • Right-Sided Endocarditis (Tricuspid or Pulmonary valves): The right side of the heart pumps blood directly to the lungs. Emboli here usually cause septic pulmonary emboli (blockages in the lungs), leading to chest pain, shortness of breath, and lung abscesses [15].

Who is at the Highest Risk?

Your medical team evaluates your individual risk of an embolus based on several factors:

  • Vegetation Size and Mobility: Vegetations larger than 10 millimeters, or those that are seen moving loosely (highly mobile) on an echocardiogram, are more likely to break off [16][9].
  • Type of Bacteria: Infections caused by Staphylococcus aureus or certain fungi carry a higher embolic risk [9][17].
  • Valve Location: Mitral valve infections tend to have a higher risk of systemic embolic events [9].
  • Previous Emboli: If you have already had an embolus, the risk of having another one is higher [18].

How is the Risk Managed?

The goal of treatment is to cure the infection and stabilize the vegetations before they can break apart.

  • Intravenous (IV) Antibiotics: Starting the right antibiotics early is essential. While clearing your blood cultures proves the bacteria in your bloodstream are responding to treatment, antibiotics do not instantly shrink the vegetation or immediately drop your embolic risk to zero [19][20]. Risk gradually decreases as the infection heals. Do not stop or change your antibiotics without direct instructions from your treating team.
  • Heart Valve Surgery: Some patients need open-heart surgery to remove the infected tissue and repair or replace the valve. While a large vegetation (e.g., over 10 millimeters) is a risk factor, size alone is not an automatic rule for surgery [21]. A multidisciplinary endocarditis team will weigh the vegetation’s size and mobility alongside other factors like heart failure, persistent infection, previous emboli, and the type of bacteria before recommending early surgery [22][23].

Common questions in this guide

What is an embolus in infective endocarditis?
An embolus is a piece of an infected growth, called a vegetation, that breaks away from a heart valve and travels through the bloodstream. It can block blood flow to an organ or carry infection to a new site, where a pocket of infection or a weakened infected blood vessel may develop.
Where can an embolus from endocarditis travel?
With left-sided endocarditis, emboli can travel to the brain, spleen, kidneys, arms or legs, or heart. A brain blockage can cause a stroke, while kidney or spleen blockage may cause pain or kidney injury. With right-sided endocarditis, emboli usually travel to the lungs and can cause chest pain, shortness of breath, or lung abscesses.
What symptoms from endocarditis emboli mean I should call emergency services?
Call emergency services immediately for sudden facial or limb drooping, trouble speaking or understanding, sudden vision loss, a new severe headache, severe chest, back, or abdominal pain, extreme shortness of breath, or an arm or leg that becomes cold, pale, or painful. Do not wait for symptoms to improve or for a scheduled appointment, because these signs can indicate a stroke or blocked blood vessel.
Who is more likely to have an embolus with infective endocarditis?
Risk is higher when a valve vegetation is larger than 10 millimeters or moves freely on an echocardiogram. Staphylococcus aureus or certain fungal infections, infection of the mitral valve, and a previous embolus also increase risk. Your endocarditis team combines these findings with your overall condition to estimate risk.
Does starting antibiotics make embolic risk disappear right away?
No. Embolic risk is often highest early in infective endocarditis and generally falls as antibiotics control the infection, but the vegetation may not shrink immediately. Take antibiotics exactly as prescribed and do not stop or change them without your treating team’s instructions.
When might surgery be considered to prevent emboli?
An endocarditis team may consider early heart valve surgery when the vegetation is large or mobile, especially alongside heart failure, infection that persists despite treatment, previous emboli, or certain organisms. A vegetation larger than 10 millimeters alone does not automatically mean surgery is needed; the team weighs the risks and benefits and may remove infected tissue or repair or replace the valve.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How large are the vegetations on my heart valves, and do they look highly mobile on the echocardiogram?
  2. 2.Are my blood cultures clearing, and how does this affect my ongoing treatment plan and embolic risk?
  3. 3.Based on the size of my vegetation, the specific bacteria, and my valve function, does the endocarditis team recommend early surgery?
  4. 4.What specific warning signs for my type of endocarditis (left-sided vs. right-sided) should prompt an immediate trip to the emergency room?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (23)
  1. 1

    Post-mortem findings in Staphylococcus aureus acute infective endocarditis.

    Phogat D, Bajpai M, Ganguli P, Upreti V

    Autopsy & case reports 2020; (10(4)):e2020212 doi:10.4322/acr.2020.212.

    PMID: 33344326
  2. 2

    Portraying infective endocarditis: results of multinational ID-IRI study.

    Erdem H, Puca E, Ruch Y, et al.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2019; (38(9)):1753-1763 doi:10.1007/s10096-019-03607-x.

    PMID: 31187307
  3. 3

    Posterior Mitral Valve Acute Infective Endocarditis Complicated With Brain Abscess and Infection-Related Glomerulonephritis: A Case Report.

    Mithuriha M, Hettiarachchi R, Balachandran T

    Cureus 2026; (18(2)):e102782 doi:10.7759/cureus.102782.

    PMID: 41783886
  4. 4

    Neurologic complications of infective endocarditis.

    Chakraborty T, Rabinstein A, Wijdicks E

    Handbook of clinical neurology 2021; (177()):125-134 doi:10.1016/B978-0-12-819814-8.00008-1.

    PMID: 33632430
  5. 5

    Comprehensive Assessment of the Risk of Symptomatic Embolism in Patients With Infective Endocarditis.

    Santos-Patarroyo SD, Quintero-Martinez JA, Lahr BD, et al.

    Journal of the American Heart Association 2025; (14(3)):e036648 doi:10.1161/JAHA.124.036648.

    PMID: 39846279
  6. 6

    Asymptomatic and symptomatic embolic events in infective endocarditis: associated factors and clinical impact.

    Monteiro TS, Correia MG, Golebiovski WF, et al.

    The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2017; (21(3)):240-247 doi:10.1016/j.bjid.2017.01.006.

    PMID: 28263711
  7. 7

    Mind the Gap: Inadequate Performance of Embolic Risk Scores in Infective Endocarditis.

    Ianculescu N, Monney P, Epprecht J, et al.

    Open forum infectious diseases 2026; (13(5)):ofag280 doi:10.1093/ofid/ofag280.

    PMID: 42211863
  8. 8

    Time-sensitive predictors of embolism in patients with left-sided endocarditis: Cohort study.

    Yang A, Tan C, Adhikari NKJ, et al.

    PloS one 2019; (14(4)):e0215924 doi:10.1371/journal.pone.0215924.

    PMID: 31022279
  9. 9

    Clinical and echocardiographic predictors of embolism in infective endocarditis: systematic review and meta-analysis.

    Yang A, Tan C, Daneman N, et al.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2019; (25(2)):178-187 doi:10.1016/j.cmi.2018.08.010.

    PMID: 30145401
  10. 10

    Prevalence of neurological complications in infective endocarditis.

    Rodríguez-Montolio J, Meseguer-Gonzalez D, Almeida-Zurita M, et al.

    Neurologia 2024; (39(6)):443-448 doi:10.1016/j.nrleng.2021.09.009.

    PMID: 37085083
  11. 11

    Acute abdomen revealed Streptococcus gordonii infective endocarditis with systemic embolism.

    Chang CY, Gan YL, Radhakrishnan AP, Ong ELC

    Oxford medical case reports 2022; (2022(1)):omab145 doi:10.1093/omcr/omab145.

    PMID: 35083058
  12. 12

    A case of fatal infective endocarditis in uncorrected tetralogy of Fallot with persistent left superior vena cava.

    Richard RS, Mathew D, Chaudhari VA, Kaur K

    Journal of forensic sciences 2025; (70(6)):2546-2551 doi:10.1111/1556-4029.70142.

    PMID: 40739702
  13. 13

    Systemic Embolization as the Initial Presentation of a Rare Cause of Infective Endocarditis.

    Riaz S, Sampat PJ, Khan A, et al.

    Cureus 2020; (12(6)):e8472 doi:10.7759/cureus.8472.

    PMID: 32528787
  14. 14

    Infective endocarditis complicated with coronary artery septic embolization: is it worth to be mentioned? Case presentation and review of the literature.

    Bitay M, Varga S, Babik B, et al.

    Reviews in cardiovascular medicine 2019; (20(1)):35-39 doi:10.31083/j.rcm.2019.01.4241.

    PMID: 31184094
  15. 15

    Vascular Complications of Infective Endocarditis: Diagnosis and Management.

    Ibtisam K, El Bekkaoui M, Skiker I, et al.

    Cureus 2021; (13(4)):e14678 doi:10.7759/cureus.14678.

    PMID: 34055524
  16. 16

    Association of Vegetation Size With Embolic Risk in Patients With Infective Endocarditis: A Systematic Review and Meta-analysis.

    Mohananey D, Mohadjer A, Pettersson G, et al.

    JAMA internal medicine 2018; (178(4)):502-510 doi:10.1001/jamainternmed.2017.8653.

    PMID: 29459947
  17. 17

    A retrospective epidemiologic study to define risk factors, microbiology, and clinical outcomes of infective endocarditis in a large tertiary-care teaching hospital.

    Mostaghim AS, Lo HYA, Khardori N

    SAGE open medicine 2017; (5()):2050312117741772 doi:10.1177/2050312117741772.

    PMID: 29163950
  18. 18

    Prediction of Symptomatic Embolism in Filipinos With Infective Endocarditis Using the Embolic Risk French Calculator.

    Aherrera JA, Abola MT, Balabagno MM, et al.

    Cardiology research 2016; (7(4)):130-139 doi:10.14740/cr490w.

    PMID: 28197281
  19. 19

    Recurrent Systemic Embolization From Bicuspid Aortic Valve Endocarditis in the Setting of Anti-coagulation Use.

    Rafique S, Fernandez S, Saleem S, Akram S

    Cureus 2024; (16(11)):e73187 doi:10.7759/cureus.73187.

    PMID: 39651010
  20. 20

    Normal procalcitonin, C-reactive protein, and negative blood cultures in infective endocarditis with a massive residual vegetation: a case report.

    Farandzha D, Shikerova P, Lazarova G, Hazarbasanov D

    European heart journal. Case reports 2021; (5(9)):ytab312 doi:10.1093/ehjcr/ytab312.

    PMID: 34622133
  21. 21

    Reassessment of Vegetation Size as a Sole Indication for Surgery in Left-Sided Infective Endocarditis.

    Cabezón G, López J, Vilacosta I, et al.

    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2022; (35(6)):570-575 doi:10.1016/j.echo.2021.12.013.

    PMID: 34971762
  22. 22

    Current AATS guidelines on surgical treatment of infective endocarditis.

    Pettersson GB, Hussain ST

    Annals of cardiothoracic surgery 2019; (8(6)):630-644 doi:10.21037/acs.2019.10.05.

    PMID: 31832353
  23. 23

    Systemic embolization in infective endocarditis.

    Kildahl HA, Brenne EL, Dalen H, Wahba A

    Indian journal of thoracic and cardiovascular surgery 2024; (40(Suppl 1)):40-46 doi:10.1007/s12055-023-01616-2.

    PMID: 38827555

This page explains embolic risks in infective endocarditis for informational purposes only and does not constitute medical advice. Your treating team must assess your personal risk; call emergency services for sudden stroke-like symptoms, severe breathing difficulty, severe chest or abdominal pain, or a cold, painful limb.

Get notified when new evidence is published on Infective endocarditis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.